In this study, using EGF as an EMT-inducing factor in human cervical cancer cells, we explored the regulatory roles of miR155 in the EMT process, cellular proliferation, cellular sensitivity to chemotherapeutic drugs, and evaluated the potential value of miR155 as a molecular target for the early prevention of cervical cancer invasion and metastasis. This evidence concerns the gene EGF and cervical carcinoma.